focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

10 Apr 2024 07:00

RNS Number : 9300J
Chamberlin PLC
10 April 2024
 

10 April 2024

 

Chamberlin plc

("Chamberlin", the "Company" or the "Group")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and machining group, announces a trading update in respect of the three-month period ending 29 February 2024 ("Q3 FY24") and outlook for the final quarter of FY24 ending 31 May 2024 ("Q4 FY24").

 

Underlying demand across the Group during Q3 FY24 was below management's expectations. Schedules over the period were lower than previously forecast by our customers and were further impacted by delays with the startup of certain new programs. Encouragingly, demand from customers in the renewable offshore energy market remained very strong, but the majority of other market sectors were affected by a slowdown in immediate demand.

 

Lower sales during Q3 FY24 have negatively affected profitability and working capital, however the management team are taking appropriate action to mitigate the impact now and going forward.

 

The slowdown has started to improve during Q4 FY24 and customer schedules are recovering to a more normalised and stable level, with a strong uptick in demand forecast within the next 6-month period as new programs start to ramp up production.

 

Following a full strategic review, a program of cost reduction actions have been implemented across the Group including labour reductions, short time working (as required) and senior management restructuring. Alongside this, the Company has conducted a full review of product margins and implemented price increases accordingly to underpin the required profitability and cash generation. The Group is expected to benefit from these actions within 3 months and create a more robust level of profitability going forward.

 

As previously announced, balance sheet debt following the sale of Petrel Ltd has greatly improved and the Company remains focused on paying off the remainder of its legacy debt within the next 12-month period (excluding the remaining pension deficit and HSBC invoice finance facility). Working capital levels are being monitored closely following recent performance and the steps being taken by the management team are expected to improve this position going forward.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Chamberlin plc

Kevin Price, Chief Executive

Alan Tomlinson, Finance Director

 

 

T: 01922 707100

Cavendish Capital Markets Limited

(Nominated Adviser and Joint Broker)

Katy Birkin

Stephen Keys

George Lawson

 

 

T: 020 7220 5500

Peterhouse Capital Limited

(Joint Broker)

Lucy Williams

Duncan Vasey

T: 020 7469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUBCCUPCGQB
Date   Source Headline
9th May 20184:30 pmRNSHolding(s) in Company
9th May 20184:30 pmRNSHolding(s) in Company
12th Apr 20187:00 amRNSTrading Update
26th Mar 20187:00 amRNSBoard Appointment
22nd Jan 20187:00 amRNSMachining claim update
6th Dec 20177:00 amRNSDirectors' Interests
1st Dec 20177:00 amRNSBoard Change
28th Nov 20177:00 amRNSHalf-year Results
18th Oct 20177:00 amRNSTrading Update
20th Jul 201711:48 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
5th Jun 20177:00 amRNSHolding(s) in Company
23rd May 20177:00 amRNSFinal Results
11th Apr 20177:00 amRNSTrading Update
23rd Mar 20177:00 amRNSNew Machining Facility Open Day
21st Mar 20172:24 pmRNSHardman Research: Turbo-charging into growth phase
10th Jan 20172:15 pmRNSAppointment of new Nominated Adviser and Broker
19th Dec 20165:01 pmRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSHalf-year Report
21st Nov 20167:00 amRNSTrading update
27th Sep 20161:50 pmRNSHolding(s) in Company
8th Aug 201612:43 pmRNSHolding(s) in Company
22nd Jul 20162:24 pmRNSResult of AGM
22nd Jul 20167:00 amRNSAGM Statement
18th Jul 20167:00 amRNSBoard Appointment
29th Jun 20167:00 amRNSPromoted to Category "A" supplier by IHI
24th May 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSTrading Update, New Contract & New Facility
26th Jan 20164:26 pmRNSHolding(s) in Company
26th Jan 20161:19 pmRNSHolding(s) in Company
5th Jan 20161:26 pmRNSHolding(s) in Company
1st Dec 201510:03 amRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSHalf Yearly Report
6th Aug 20157:00 amRNSChange of Adviser
4th Aug 20153:58 pmRNSHolding(s) in Company
17th Jul 20155:07 pmRNSResult of AGM
17th Jul 20157:00 amRNSAGM Statement
19th May 20157:00 amRNSFinal Results
27th Nov 20144:50 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSHalf Yearly Results
18th Nov 20147:00 amRNSMajor Contract Win
17th Oct 20147:00 amRNSMajor contract win
14th Oct 20147:00 amRNSChange of Auditor
8th Aug 20143:21 pmRNSDirector/PDMR Shareholding
1st Aug 20149:00 amRNSResult of AGM
31st Jul 20147:00 amRNSAGM Statement
20th May 20147:00 amRNSFinal Results
26th Nov 20137:00 amRNSHalf Yearly Results
31st Oct 201312:37 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.